Navigation Links
NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
Date:7/8/2008

BOSTON, July 8 /PRNewswire/ -- NorthPoint Domain, an IC Sciences company, announced today a collaboration with Boston Medical Center's (BMC) Cardiovascular Center to apply advanced Internet patient engagement "instruments" to BMC's cardiac robotic surgery program. Also known as "medical informatics instruments" (MIIs), these patient engagement tools are used by clinicians as informational and interactive tools that involve patients and their families in the care process. Built upon a web platform, informatics instruments represent a new way for clinicians to deliver medical care, making it feasible to educate and instruct patients and their families, set expectations, share decision-making, and support self-care in ways heretofore not possible.

The partnership unites the industry's most potent cardiovascular patient engagement instruments with one of the most innovative cardiac surgery programs in the country, and is an extension of the long-standing relationship between NorthPoint Domain and the BMC Cardiovascular Center. The organizations have collaborated since 2002 to use web-based MIIs to advance patient-centered care. NorthPoint Domain will work with the Cardiovascular Center to tailor its MII platforms, complementing the advanced robotic surgery technology currently being used at BMC. "NorthPoint Domain will greatly enhance our ability to inform and engage our patients and make them true partners in their own care," said Robert S. Poston, MD, Chief of Cardiac Surgery at BMC and Associate Professor of Cardiothoracic Surgery at Boston University School of Medicine.

Rony Sellam, President and Chief Operating Officer of NorthPoint Domain, added, "While BMC is among a handful of medical centers in the country offering minimally invasive robotic CABG, it will be the only center in the world combining this with our Internet instruments for informatics-powered care delivery."

Healthcare participants use MIIs developed and delivered by IC Sciences and NorthPoint Domain to provide a new generation of healthcare -- informed clinical care. This is patient-centered medicine enlightened and informed by MII-generated experience, evidence, prediction, and preference data. MIIs can provide potent functionality for partnering with and activating patients to participate in their care.

A burgeoning scientific evidence base, including a review of 24 randomized controlled trials, indicates that in chronic condition management patient engagement instruments achieve significant improvements not only in patient knowledge, care support, and behavioral outcomes, but also in clinical outcomes. (Murray et al) The partners expect to see similar benefits in the acute cardiac surgery care setting and are exploring future clinical studies to assemble an evidence base.

References

Murray E, et al. 2005. Interactive health communication applications for people with chronic disease. The Cochrane Database of Systematic Reviews Issue 4.

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit http://www.ICSciences.com.

About NorthPoint Domain, Inc.

NorthPoint Domain, Inc., a subsidiary of IC Sciences Corporation, provides care delivery informatics instruments for the specialty specific medical practice. These Internet-based instruments are designed to engage patients, consumers, and referring clinicians, address health literacy concerns, and deliver patient care oversight. Please visit http://www.northpointdomain.com for additional information.

About the Cardiovascular Center at Boston Medical Center

Boston Medical Center is the primary teaching affiliate of the Boston University School of Medicine. The Cardiovascular Center is a regional referral center that uses state-of-the-art technology to provide high-quality, cost-effective cardiac and vascular care. The BMC Cardiovascular Center is the only hospital in Boston -- and one of a handful in the United States -- to offer minimally invasive robotically assisted coronary artery bypass surgery. For more information about the BMC Cardiovascular Center, please visit http://www.bmc.cardiologydomain.com.

CONTACT: IC Sciences Corporation

One Joy Street Boston, MA 02108

publicrelations@icsciences.com

1-800-603-1420


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NorthPoint Domain and NYU Vascular Associates Partner to Develop New Generation of Care Delivery Informatics Instruments
2. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
3. TechCFO Adds Gary Strickland as Partner in Boston Office
4. Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
5. Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
6. Boston Scientific Welcomes Revised Outlook From Fitch Ratings
7. Boston Scientific to Participate in Goldman Sachs Conference
8. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
9. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
10. Boston Scientific Completes Acquisition of CryoCor
11. Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... DrugDev customers ... Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev will join customers including ... issues such as trial performance metrics, patient enrollment diversity, protocol optimization, and global ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the ... paper by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue ... Bik joined uBiome in October 2016 from her previous position at Stanford University ...
(Date:1/18/2017)... DIEGO , Jan. 18, 2017 Shareholder ... an investigation into whether the board members of CoLucid ... fiduciary duties in connection with the proposed sale of ... a biopharmaceutical company that develops small molecules for the ... 2017, CoLucid announced it had signed a definitive merger ...
(Date:1/18/2017)... IRVING, Texas , Jan. 18, 2017 /PRNewswire/ ... science, and the Lustgarten Foundation, the largest private ... support a clinical trial evaluating the impact of ... is providing clinical trial enrollment services to identify ... and facilitate communication between treating physicians and study ...
Breaking Biology Technology:
(Date:1/12/2017)... PUNE, India , January 12, 2017 A ... 2015 - 2022," projects that the global biometric technology market is expected to generate ... to 2022. Continue Reading ... ...      (Logo: ...
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):